2012 AAN 成人阵发性偏头痛预防药物治疗循证指南

2012-04-24 美国神经病学学会 Neurology. 2012 Apr 24;78(17):1337-45.

中文标题:

2012 AAN 成人阵发性偏头痛预防药物治疗循证指南

英文标题:

Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.

发布机构:

美国神经病学学会

发布日期:

2012-04-24

简要介绍:

OBJECTIVE: To provide updated evidence-based recommendations for the preventive treatment of migraine headache. The clinical question addressed was: What pharmacologic therapies are proven effective for migraine prevention?METHODS: The authors analyzed published studies from June 1999 to May 2009 using a structured review process to classify the evidence relative to the efficacy of various medications available in the United States for migraine prevention.Results and Recommendations: The author panel reviewed 284 abstracts, which ultimately yielded 29 Class I or Class II articles that are reviewed herein. Divalproex sodium, sodium valproate, topiramate, metoprolol, propranolol, and timolol are effective for migraine prevention and should be offered to patients with migraine to reduce migraine attack frequency and severity (Level A). Frovatriptan is effective for prevention of menstrual migraine (Level A). Lamotrigine is ineffective for migraine prevention (Level A).

评论区 (1)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=995798, encodeId=8440995e987d, content=有点参考价值, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Sat Jul 03 17:08:41 CST 2021, time=2021-07-03, status=1, ipAttribution=)]
    2021-07-03 湘雅科教

    有点参考价值

    0